AIRLINK 72.59 Increased By ▲ 3.39 (4.9%)
BOP 4.99 Increased By ▲ 0.09 (1.84%)
CNERGY 4.29 Increased By ▲ 0.03 (0.7%)
DFML 31.71 Increased By ▲ 0.46 (1.47%)
DGKC 80.90 Increased By ▲ 3.65 (4.72%)
FCCL 21.42 Increased By ▲ 1.42 (7.1%)
FFBL 35.19 Increased By ▲ 0.19 (0.54%)
FFL 9.33 Increased By ▲ 0.21 (2.3%)
GGL 9.82 Increased By ▲ 0.02 (0.2%)
HBL 112.40 Decreased By ▼ -0.36 (-0.32%)
HUBC 136.50 Increased By ▲ 3.46 (2.6%)
HUMNL 7.14 Increased By ▲ 0.19 (2.73%)
KEL 4.35 Increased By ▲ 0.12 (2.84%)
KOSM 4.35 Increased By ▲ 0.10 (2.35%)
MLCF 37.67 Increased By ▲ 1.07 (2.92%)
OGDC 137.75 Increased By ▲ 4.88 (3.67%)
PAEL 23.41 Increased By ▲ 0.77 (3.4%)
PIAA 24.55 Increased By ▲ 0.35 (1.45%)
PIBTL 6.63 Increased By ▲ 0.17 (2.63%)
PPL 125.05 Increased By ▲ 8.75 (7.52%)
PRL 26.99 Increased By ▲ 1.09 (4.21%)
PTC 13.32 Increased By ▲ 0.24 (1.83%)
SEARL 52.70 Increased By ▲ 0.70 (1.35%)
SNGP 70.80 Increased By ▲ 3.20 (4.73%)
SSGC 10.54 No Change ▼ 0.00 (0%)
TELE 8.33 Increased By ▲ 0.05 (0.6%)
TPLP 10.95 Increased By ▲ 0.15 (1.39%)
TRG 60.60 Increased By ▲ 1.31 (2.21%)
UNITY 25.10 Decreased By ▼ -0.03 (-0.12%)
WTL 1.28 Increased By ▲ 0.01 (0.79%)
BR100 7,546 Increased By 137.4 (1.85%)
BR30 24,809 Increased By 772.4 (3.21%)
KSE100 71,902 Increased By 1235.2 (1.75%)
KSE30 23,595 Increased By 371 (1.6%)

KARACHI: Pharmaceutical companies in Pakistan should invest in research and development and adopt patents and licenses from multinational companies to bring the impetus to the growth of drug production across the country.

Addressing a seminar on "Intellectual Property Right, Patents, Copy write and Design" held at the 20th Pharma Asia Conference, Deputy Director at IPO Pakistan Syed Ali Mohammad Zaidi said adoption of patents in the pharmaceutical sector has a crucial role in its sustainable growth and expansion; however, a producer of medicine needs to invest on research and development. He urged pharmaceutical companies to invest in research, development and patents to have more share in the overall pie of sales and productions of the market.

Tajammul Haider, former focal person to WIPO (Geneva), said distribution companies of various products, mainly the pharmaceutical sector, should avail of the licenses from multinational companies to enhance the local production of the medicine. He added that the licensing regime will reduce the country's import bill and ensure the availability of medicine at the domestic level while enhancing the staff member's capacity. He said the need for more awareness in the export-oriented companies could not focus on these core issues; however, the government should encourage exporters to bring new technologies into the country.

Haider mentioned that WIPO systems have received a healthy response from foreign companies to get applications 18,000 for their registration and patents in Pakistan. In contrast, a few Pakistani companies made less attempts of filing application process. He urged universities and chambers of commerce to enlighten students and traders about patents, intellectual property rights, etc, to build an understanding of the importance of these topics.

Pakistan's pharmaceutical industry is a significant contributor to the economy, with an estimated value of $ 3.2 billion and a growth rate of around 15% annually.

Copyright Business Recorder, 2023

Comments

Comments are closed.